vendredi 29 juillet 2016

Onco Actu du 29 juillet 2016

2. Etiologie

Why working the night shift can pose a cancer risk [MIT News]

3.6 Prévention - Activité physique

An hour of exercise a day may compensate for an 'office lifestyle' [NHS Choices]

4.11 Dép., diag. & prono. - Ovaire

Ovarian cancer test on horizon as scientists find earliest signs of disease [The Telegraph]

4.9 Dép., diag. & prono. - Sein

Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain [Mayo Clinic]

5. Traitements

NIH-led researchers develop software that could facilitate drug development [NIH]

5.2 Pharma

AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma [AbbVie]

5.2.3 Pharma - économie

Earnings drop at Sanofi as it looks for a quick Medivation resolution [Pharmafile]

AstraZeneca earnings hit by waning cholesterol drug sales [Reuters]

Bristol-Myers beats forecasts as hepatitis, cancer drugs deliver [Reuters]

U.S. biotech Celgene raises forecast as profit beats Street [Reuters]

5.4 Traitements - Economie

Make Drugmakers Pay: England’s Strategy for Cancer Medicines [Bloomberg]

Controversial CDF revamp launches [PharmaTimes]

6. Lutte contre les cancers

I’m an immigrant and a Muslim. And I’m here to cure cancer [STAT]

NIH funds precision medicine research with a focus on health disparities [NIH]

6.4 Médico-éco

Can the NHS really not afford second transplants for cancer patients like me? [The Guardian]

6.9 Controverses

Stanford’s John Ioannidis On “underperforming Big Ideas” [Scope Blog]